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Enhanced nutrient supply and intestinal microbiota
development in very low birth weight infants
Elin W. Blakstad1,2, Katri Korpela3, Sindre Lee2, Britt Nakstad1, Sissel J. Moltu4, Kenneth Strømmen5, Arild E. Rønnestad5,6,
Kristin Brække4, Per O Iversen2,7, Willem M de Vos3,8 and Christian A. Drevon2
BACKGROUND: Promoting a healthy intestinal microbiota may have positive effects on short- and long-term outcomes in very low
birth weight (VLBW; BW < 1500 g) infants. Nutrient supply influences the intestinal microbiota.
METHODS: Fifty VLBW infants were randomized to an intervention group receiving enhanced nutrient supply or a control group.
Fecal samples from 45 infants collected between birth and discharge were analyzed using 16S ribosomal RNA (rRNA) amplicon
sequencing.
RESULTS: There was considerable individual variation in microbiota development. Microbial richness decreased towards discharge
in the controls compared to the intervention group. In the intervention group, there was a greater increase in diversity among
moderately/very preterm (MVP, gestational age ≥ 28 weeks) infants and a steeper decrease in relative Staphylococcus abundance in
extremely preterm (EP, gestational age < 28 weeks) infants as compared to controls. Relative Bifidobacterium abundance tended to
increase more in MVP controls compared to the intervention group. Abundance of pathogens was not increased in the intervention
group. Higher relative Bifidobacterium abundance was associated with improved weight gain.
CONCLUSION: Nutrition may affect richness, diversity, and microbiota composition. There was no increase in relative abundance of
pathogens among infants receiving enhanced nutrient supply. Favorable microbiota development was associated with improved
weight gain.
Pediatric Research (2019) 86:323–332; https://doi.org/10.1038/s41390-019-0412-x
INTRODUCTION
The aim of nutritional management of preterm infants is to
achieve postnatal growth similar to normal fetal growth.1 Despite
increased focus on optimizing nutrient supply, postnatal growth
failure is still common among preterm infants.2 Faster growth
between birth and term equivalent age has been associated with
improved cognitive development.3
Intestinal microbial colonization increases rapidly after birth and
is affected by several factors such as delivery mode, exposure to
antibiotics, infections, and nutrition.4 In vaginally delivered term-
born infants facultative anaerobic Proteobacteria are gradually
replaced by anaerobes such as Bifidobacterium, members of
Clostridiales, and Bacteroides.5 Preterm infants have less bacterial
diversity and increased amounts of potential pathogens com-
pared to infants born at term.6 They often have a high abundance
of enterobacteria, staphylococci, and enterococci, and low and
delayed colonization with Bifidobacterium.7
The microbiota is important for intestinal maturation, main-
tenance of the mucosal surface integrity, and protection against
pathogens.6 Alterations in the pattern of microbial colonization in
preterm infants are associated with increased risk of necrotizing
enterocolitis (NEC) and sepsis.8,9 The microbiota may affect
growth, the immune system, neurodevelopment, and future risk
of developing metabolic syndrome.6,10,11 Thus, promoting healthy
intestinal microbiota in preterm infants may have positive effects
on short- and long-term health outcomes.
Nutrition influences intestinal microbiota.12–14 Furthermore, the
intestinal microbiota may affect metabolism, through catabolism
of nutrients, production of energy, and synthesis of vitamins.6
Preterm infants receive parenteral nutrition (PN) until they tolerate
full enteral feeding. Human milk is recommended, but must be
fortified to meet the infants’ nutrient requirements.1 There is
limited knowledge on how nutrient supply affects the microbiota
in preterm infants.
In a randomized controlled trial (RCT) of very low birth weight
(VLBW, birth weight (BW) < 1500 g) infants, we observed that
enhanced nutrient supply improved postnatal growth.15 We also
demonstrated that intestinal microbiota development among
infants in this cohort was associated with postnatal age and post-
menstrual age (PMA).16 Microbiota development among extre-
mely preterm infants (EP, gestational age (GA) < 28 weeks)
appeared delayed when compared to microbiota development
of moderately/very preterm (MVP, GA ≥ 28 weeks) infants.16
However, when adjusting for PMA, microbiota development
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among EP infants was more similar to that of MVP infants.
Richness increased after birth with an initial dominance of
Staphylococcus, followed by Enterococcus, Enterobacter, and finally
Bifidobacterium.16 The Enterococcus phase was mainly observed
among EP infants and may have delayed microbiota maturation.16
We also observed that antibiotic use had a strong, but temporary
effect on microbiota development and that the response
depended on the sensitivity of the microbe to the antibiotic.16
In the present study, we describe the effects of nutrient supply on
microbiota development in VLBW infants.
METHODS
Study design
The RCT was conducted in 2010 at Akershus University Hospital and
Oslo University Hospital. The study was approved by the Regional
Committee for Medical and Health Research Ethics and registered
in ClinicalTrials.gov (NCT01103219). VLBW infants were eligible for
inclusion. Exclusion criteria were congenital malformations, chro-
mosomal abnormalities, critical illness with short life expectancy,
and clinical syndromes known to affect growth and development. A
sample size of 120 infants in each group was calculated based on
the primary outcome of the RCT, which was to reduce the
proportion of postnatal growth-restricted infants.15 Infants were
recruited by a primary investigator or the attending physician and
were randomized (computer-generated block randomization) to an
intervention or a control group. Sealed opaque envelopes were
opened after informed parental consent was obtained. The study
was not blinded. Infants were classified as either EP or MVP. After
inclusion of 50 infants, a safety analysis revealed increased
incidence of late-onset sepsis in the intervention group and further
inclusion was stopped.15 Three infants died (control group) and two
infants were excluded due to critical illness and congenital heart
disease (control group), leaving 45 infants with fecal samples for
analysis (Fig. 1). Forty-four infants had complete nutritional and
growth data for the first four postnatal weeks (Fig. 1).
Nutritional intervention
A detailed description of the nutrition protocol has been
reported previously.15 The intervention group started with
3.5 g amino acids/kg/day and 2.0 g/kg/day of a lipid emulsion
containing fish oil (SMOF, Fresenius Kabi, Norway). The control
group started with 2.0 g amino acids/kg/day and 0.5 g/kg/day of
a lipid emulsion (ClinOleic, Baxter, Norway). Parenteral supply
was gradually increased in both groups during the first days of
life. All infants received minimal enteral feeding with human
milk (mother’s or donor milk) in similar volumes from the first
day of life (Table 1, Supplemental Fig. S1). Donor milk was frozen
and not pasteurized. As enteral milk volumes were increased,
parenteral supply was reduced. Time to reach full enteral
feeding was similar between groups (Table 1). In both groups,
fortification with Nutriprem® (Nutricia, Norway) was initiated
when 110 mL/kg/day of milk was tolerated (Table 1). The
intervention group received additional supply of amino acids
(0.6 g Complete Amino Acid Mix®/100 mL human milk, Nutricia).
From day 6, the intervention group received 60 mg/kg/day each
of docosahexaenoic acid (DHA) and arachidonic acid (ARA)
(Formulaic, Martek Biosciences Corporation, Columbia, MD, USA)
diluted in MCT oil as well as 1500 µg/kg/day of vitamin A (Aas
Laboratory, Norway) diluted in groundnut oil. The intervention
group received significantly more energy, fat, protein, vitamin A,
ARA, and DHA as compared to the control group, whereas
enteral feeding volumes and carbohydrate supplies were similar
(Supplemental Fig. S1). Median supply of energy and nutrients
were higher in the intervention group as compared to the
control group during the first 4 weeks: energy (139 kcal/kg/day
vs. 126 kcal/kg/day, P < 0.001); fat (7.3 g/kg/day vs. 5.9 g/kg/day,
P < 0.001); protein (4.0 g/kg/day vs. 3.2 g/kg/day, P < 0.001); DHA
(87 mg/kg/day vs. 36 mg/kg/day, P < 0.001); ARA (68 mg/kg/day
vs. 24 mg/kg/day, P < 0.001); vitamin A (1300 µg/kg/day vs.
252 µg/kg/day, P < 0.001).15 The nutritional intervention contin-
ued to 52 weeks PMA or until a body weight of 5.5 kg was
reached.
Anthropometric data
Weight, length, and head circumference (HC) were registered at
birth and during hospital stay. Non-sex-specific z-scores for length
and HC were calculated using Fenton growth charts until 36 weeks
PMA (http://uccalgary.ca/fenton). Sex-specific weight z-scores were
obtained from Skjaerven’s growth charts until 36 weeks PMA.17
Fecal sampling
Fecal samples were collected approximately every 1–2 weeks from
birth until discharge. Fresh samples were collected from diapers,
frozen at −80 °C, and kept frozen during transport to the
laboratory for analysis.
Sequencing and preprocessing
The microbial composition of fecal samples was quantified
performing 16S rRNA amplicon sequencing using the Illumina
MiSeq system. DNA was extracted using the repeated bead
beating and the V1–V3 primers forward AGAGTTTGATCMT
57 eligible infants
50 infants included
Intervention group (n = 24) Control group (n = 26)
Fecal samples (n = 24) Fecal samples (n = 21)
Nutritional data (n = 21)Nutritional data (n = 23)
1 died
3 died
2 excluded (critical illness and
congenital heart disease)
7 infants not included:
1 parental consent refusal
3 critical sick mother/siblings
1 congenital anomaly
2 omissions during enrollment
Fig. 1 Flow chart of very low birth weight infants
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GGCTCAG and reverse GTATTACCGCGGCTGCTG were used for
sequencing.18 The sequences were pre-processed using the
R-package mare,19 applying USEARCH for quality filtering, cluster-
ing of sequences into species-like operational taxonomic units
(OTUs), and for taxonomic annotation.20 We did not assign
taxonomies to the OTUs because OTU clustering is a potential
source of taxonomic errors. Instead, we assigned taxonomies to
the sequences and formed taxonomic tables directly based on the
abundance of the annotated sequences. We used Silva as a
reference database, refined by excluding non-gut-associated
taxa.21 Our approach was validated by analyses of artificial
microbial communities of known composition.19 We only used
quality-filtered forward sequences truncated to 150 nucleotides
(nt) as this approach removes low-quality bases at the end of the
sequence.16 The results of this approach correspond better to the
actual composition in artificial communities, as compared to using
long, merged paired-end sequences.15 Furthermore, we removed
all sequences representing <0.001% of the total sequences
because rare sequences are likely to contain errors or chimaeras.
After quality filtering, the average number of sequences per
sample was 68,000, ranging from 23 to 282,000. The sequencing
run also contained 14 empty samples as negative controls.
Calculations of microbial indexes
Microbial richness was measured as the number of species-like
OTUs. Diversity was estimated using the inverse Simpson diversity
index. Microbiota development index was calculated as the sum of
the first two principal coordinates as previously described.16 The
principal coordinate’s analysis summarizes the microbiota into a
few coordinates. The first two coordinates, especially the sum of
their scores, strongly correlate with infant age and is therefore an
indication of microbiota development.16
Statistical analyses
Group differences in clinical characteristics and anthropometric data
were evaluated with Student’s t tests or Mann–Whitney’s U test for
continuous variables, and χ2 or Fisher’s exact tests for categorical
variables. Results are presented as means (ranges/standard devia-
tions), frequencies (%), or medians (interquartile ranges).
Microbiota responses were modeled using a repeated-measures
linear mixed model. The model was constructed with random
intercepts for each infant, and random slope for each group. This
approach permitted infants to have unique starting scores, and
allowed responses over time to vary depending on different
conditions. The mixed model tested postnatal age, group, and
postnatal age by group effects and included GA at birth, total
sequence numbers, and use of antibiotic within 5 days prior to fecal
sampling as covariates. Adjustment for BW or birth BW z-score were
also performed. The infants were regrouped into those: (1) with
positive or negative changes in weight z-scores; and (2) receiving
PN for <10 days or PN for ≥10 days. Subsequently, the data were
reanalyzed using the same mixed models as described above, but
with new grouping factors. In addition to BW or BW z-scores, these
models were adjusted for other covariates that differed between
the groups (small for gestational age (SGA), incidence of sepsis, and
the volume of human milk intake first day of life). For the PN
analyses, the first fecal samples obtained after the PN period were
regarded as baseline for each infant.
If necessary, data was log-transformed (ln) to approximate
normal distribution. Significance was assumed for P < 0.05.
Statistical analyses were performed in SPSS, version 24 (SPSS,
Chicago, IL, USA) and R version 3.5.1 (R Core Team 2014).
RESULTS
Clinical characteristics and outcomes
Clinical characteristics, anthropometric measurements, nutrition,
and antibiotic treatment are presented in Table 1. BW was
significantly lower in the intervention group as compared to the
control group. When the group was split into EP and MVP infants,
there were no significant differences in anthropometric measures
at birth between the EP intervention and EP control groups. In
contrast, among the MVP infants, the intervention group had
significantly lower weight, weight z-score, HC and HC z-scores at
birth as compared to the controls. The intervention group showed
improved weight and head growth at 36 weeks PMA compared to
the controls,15 and among the MVP infants the intervention group
also demonstrated better linear growth (Table 1).
Sepsis was more common among infants in the intervention
group as compared to controls, albeit the difference was not
significant in MVP and EP groups (Table 1). All except two infants
received intravenous antibiotics, which was usually started
within the first day of life (Table 1). Although mean days with
antibiotics were higher in the intervention group, the difference
was not significant (Table 1). The first antibiotic course was
gentamycin usually combined with ampicillin. Later, gentamycin,
ampicillin/ekvacillin, vancomycin, cephalosporins or metronida-
zole were used.
Nutrition and microbiota development
Two hundred and sixty-four fecal samples were collected from 45
infants between birth and discharge (Supplemental Table S1).
There was considerable individual variation in microbiota devel-
opment and composition (Fig. 2a–h). Microbial richness increased
after birth (β= 0.35 OTUs per week, P < 0.001) and peaked
between postnatal day 20 and 50 depending on groups (Fig. 2a).
Following this peak, infants in the intervention group maintained
their richness levels, whereas the control group exhibited a
decline (β=−0.43 OTUs per week, P= 0.010). Microbial diversity
increased with postnatal age (β= 0.08 per week, P= 0.008),
peaking around postnatal day 20–55 depending on the groups
(Fig. 2b). Among MVP infants, the intervention group demon-
strated a greater increase in microbial diversity up until postnatal
day 40 as compared to MVP controls (β= 0.23 per week, P <
0.001). In EP infants, we observed no significant differences in
microbial diversity responses between the control and interven-
tion group. After the peak, microbial diversity decreased in all
groups until the end of the study period (β=−0.23 per week, P=
0.009) with no significant differences between the groups (Fig. 2b).
The microbiota development index increased with postnatal age
(β= 0.22 per week, P < 0.001) (Fig. 2c). We observed no significant
effect of the nutritional intervention on the microbiota develop-
ment index.
There were large individual variances in the abundances of
different microbes (Fig. 2d–g and Supplementary Fig. S2).
Staphylococcus abundance was high directly after birth, but
decreased in MVP (β=−18.1%, P= 0.003) and EP groups (β=
−7.7%, P < 0.001) to very low levels between postnatal days 20
and 40 (Fig. 2d). This decrease was similar for the control and
intervention MVP groups, but steeper in EP intervention group as
compared to EP control group (β=−38.5% per week, P= 0.035).
However, the initial relative abundance of Staphylococcus
appeared higher in EP intervention group infants as compared
to EP controls (Fig. 2d). The relative abundance of Enterococcus
increased to a peak around postnatal day 15 for MVP (β= 5% per
week, P= 0.010) and 25 for EP infants (β= 20.4% per week, P <
0.001), and subsequently decreased to low levels between
postnatal days 45 and 55 (Fig. 2e). The relative abundance of
Enterobacter increased after birth to a peak around postnatal day
20 in MVP (β= 7.6% per week, P < 0.001), and postnatal day 50 in
EP infants (β= 3.7% per week, P < 0.001). There were no
significant effects of nutritional intervention on the relative
abundance of Enterococcus and Enterobacter (Fig. 2e, f). The
relative abundance of Bifidobacterium abundance increased after
birth in MVP infants (β= 8.4% per week, P < 0.001) and EP infants
(β= 3.0% per week, P < 0.001) (Fig. 2g). Among MVP infants, the
Enhanced nutrient supply and intestinal microbiota development in very. . .
E. W. Blakstad et al.
326
Pediatric Research (2019) 86:323 – 332
control group exhibited a tendency to a greater increase in
Bifidobacterium abundance as compared to the intervention group
(3.2% per week, P= 0.056).
The sum of the remaining minor microbial communities
decreased from birth until postnatal day 30 (β=−4.5% per week
on average across all groups, P < 0.001) (Fig. 2g). This decrease
may reflect the initial decrease in Bacillales abundance (Supple-
mental Fig. S2a). The relative abundance of the remaining minor
microbial communities increased from postnatal day 30 among EP
infants as compared to MVP infants (β= 4.6% per week, P=
0.014). Among EP infants, the intervention group exhibited a
steeper increase in the abundance of the remaining minor
microbial towards the end of the study, as compared to the
control group (3.9% per week, P= 0.015) (Fig. 2h). The low
abundance microbes are presented in Supplemental Fig. 2. Briefly,
the relative abundance of Escherichia–Shigella (average abun-
dance 2.65%) increased with age (β= 1.6% per week across all
groups, P < 0.001), but less among infants in the intervention
group as compared to controls (β=−0.69% per week, P < 0.001).
The relative abundance of Klebsiella (average abundance 2.59%)
was briefly lower in EP infants in the intervention group between
days 21 and 29, as compared to the other groups (β=−13.3%,
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P= 0.005). The relative abundance of Propionibacterium (average
abundance 0.31%) was higher in the intervention group infants as
compared to controls (β= 0.28%, P= 0.002). Clostridium abun-
dance was very low (average abundance 0.03%), and we were
unable to perform statistical inference with certainty (data not
shown).
Microbial responses and growth
Fourteen (61%) infants in the intervention group improved their
weight z-scores, whereas nine (39%) had negative changes in
weight z-scores between birth and 36 weeks PMA. This was
significantly different (p= 0.002) from the control group, where 3
(14%) infants had a positive weight z-score change and 18 (86%)
had a negative weight z-score change. The clinical characteristics
and outcomes of the infants with positive and negative z-score
changes are compared in Supplemental Table 2. The infants with
improved weight z-scores changes had lower BW z-scores, birth
HC z-scores, and more infants were SGA at birth as compared to
infants with negative weight z-score changes. Infants with better
growth also received higher volumes of human milk during the
first day of life. Infants with a positive change in weight z-scores
between birth and 36 weeks PMA (n= 17) exhibited a larger
increase in microbial richness (β= 0.27 per week, P= 0.028) and in
relative abundance of Bifidobacterium (β= 2.30% per week, P=
0.027) as compared to infants with a negative change weight
z-score (n= 27) (Fig. 3). We did not detect any significant
associations to low abundance microbes (Supplementary Fig. 3).
Adjusting for BW z-scores and SGA status at birth did not change
the conclusion of the results. The difference in richness was no
longer significant after adjusting for volume of human milk supply
during first day of life (P= 0.25).
Microbial responses and PN
All infants received PN. We compared microbiota responses
between infants receiving PN for <10 days (mean 7.6 days, n= 31)
with infants in need of PN ≥10 days (referred to as prolonged PN,
mean 16.1 days, n= 14). Clinical characteristics and outcomes
among infants in the PN groups are compared in Supplemental
Table 2. The infants receiving prolonged PN, had lower anthro-
pometric measures at birth, higher incidence of sepsis, and more
days on antibiotics as compared to infants on PN for <10 days.
Infants with prolonged PN exhibited reduced microbial diversity
(β=−0.37, P= 0.043) and reduced microbial richness (β=−1.2,
P= 0.050) the first 33 days after birth (Fig. 4a, b), but no
differences were observed thereafter (Fig. 4a, b). We observed no
significant difference in the microbiota development index. The
relative abundance of Enterococcus was higher the first 26 days
(β= 24.8, P= 0.022) among the infants on prolonged PN, but no
differences were observed thereafter (Fig. 4e). We observed no
significant differences in abundances of Staphylococcus, Enter-
obacter, or Bifidobacterium (Fig. 4d, f, g). The differences were no
longer significant after adjusting for BW, but infants with
prolonged PN exhibited a tendency for lower microbial diversity
(P= 0.073) and richness (P= 0.078). After adjusting for sepsis,
there were no significant differences between PN groups. The sum
of abundances of minor microbial communities was lower until
55 days after birth (β=−8.1, P= 0.044) among the infants on
prolonged PN, but no difference was observed thereafter (Fig. 4h).
We did not detect any significant associations to specific low
abundance microbes (Supplementary Fig. 4).
DISCUSSION
We compared enhanced nutrient supply to standard nutrient
supply among VLBW infants and investigated the effects on
intestinal microbiota development. The microbial responses varied
considerably between individuals and few significant differences
were detected when comparing the groups with different nutrient
supplies. Infants receiving increased nutrient supply appeared to
maintain microbial richness levels better than infants on standard
nutrient supply. Moreover, in the early samples MVP infants with
increased nutrient supply had a steeper increase in diversity and
EP infants with increased nutrient supply had a more pronounced
decline in Staphylococcus as compared to infants with standard
supply. However, the relative abundance of Bifidobacterium
tended to increase more among MVP infants with standard
nutrient supply as compared to MVP infants with increased
nutrient supply. The intervention did not appear to affect the
abundance of Enterococcus or Enterobacter or enhance the
abundance of other potential pathogenic bacteria. In additional
analyses, we observed that a larger increase in richness and
relative abundance of Bifidobacterium was associated with
improved weight z-scores.
Microbial richness and microbiota development index increased
with postnatal age among the infants in our study.16 The initial
increase in richness was not affected by increased nutrient supply.
After richness peaked, the levels declined among the infants with
standard nutrient supply as compared to infants with increased
supply, who seemed to maintain their richness levels better.
Furthermore, we observed a larger increase in microbial diversity
among the MVP infants receiving enhanced nutrients as
compared to the infants on standard supply. Previous studies
have reported that preterm infants have reduced richness and
diversity.7,22 Chernikova et al.22 showed that preterm infants had
lower richness than term-born controls and that diversity declined
with decreasing GA at birth. Low microbial diversity along with
disruption of normal bacterial colonization may increase the risk of
developing sepsis and NEC in preterm infants.23–26
Four major bacterial genera were detected in the fecal samples
of the infants in our study; Staphylococcus, Enterococcus,
Enterobacter, and Bifidobacterium.16 We observed a steeper decline
in Staphylococcus in the EP intervention group compared to the EP
controls. However, the relative abundance of Staphylococcus was
higher just after birth in the EP intervention group and this may
have affected the results, despite adjusting for baseline variation.
Staphylococcus are neonate-type bacteria that quickly decline after
birth.27,28
The relative abundance of Bifidobacterium increased with
postnatal age, but there was a tendency to a greater increase
among the MVP infants receiving standard nutrient supply as
compared to the MVP infants receiving increased nutrients.
However, the lower relative abundance of Bifidobacterium in the
MVP infants with increased nutrients could be a consequence of
higher abundance of other microbes and not necessarily less
Bifidobacterium, suggested by the increase in diversity and
maintenance of richness seen in this group. Other studies
show that preterm infants have very low abundance of
Bifidobacterium.7,22 A recent study reported Bifidobacterium
abundance of 3% in preterm samples and 15% in term samples
during the first 6 weeks of life.22 In contrast to other preterm
cohorts, our infants had more Bifidobacterium in their later
samples and they even obtained similar levels to that of term-
born infants.22 All infants in our cohort received equal amounts of
unpasteurized human milk from the first day of life. Human milk
oligosaccharides, naturally found in mother’s milk, promote
Bifidobacterium colonization.14
We did not detect significant differences between the nutrient
groups in the alterations of Enterococcus. Enterococcus has been
identified in fecal samples of both term and preterm infants.7,29
The implication of Enterococcus colonization in preterm infants’
intestines is not clear. Whereas Enterococcus may be a potential
pathogen,30 this microbe has been found to modulate inflamma-
tion31 and to be more frequent among healthy preterm infants as
compared to those with NEC or sepsis.32 However, we previously
observed that increased relative abundance of Enterococcus may
inhibit normal microbiota succession.16
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Dysbiosis is a distortion in normal development of the
intestinal microbiota, and may increase the risk of NEC and
sepsis in preterm infants.24,26 Although different microbes have
been seen in association with disease, increased abundance of
gammaproteobacteria and less Bifidobacterium have been seen
in infants with NEC.10,23,24,33 We did not observe any effects of
increased nutrient supply on the relative abundance of
Enterobacter. In general, we found very low abundances of other
potential pathogens such as Klebsiella, Escherichia–Shigella, and
Clostridum.30,33 We speculate that the paucity of these microbes,
similar to the higher relative abundance of Bifidobacterium, may
be due to the beneficial effects of early use of human milk.
Enhanced nutrient supply did not increase the abundance of
potential pathogens. On the contrary, we observed a brief period
of lower abundance of Klebsiella among EP infants receiving
increased amounts of nutrients, as compared to the other study
groups. The relative abundance Escherichia–Shigella increased
more among infants with standard nutrient supply as compared
to infants with enhanced nutrient supply. A recent study
observed that Escherichia–Shigella abundance increased prior
to late-onset NEC, whereas Clostridium abundance increased
before early-onset NEC.33
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The intervention group had a higher relative abundance of
Propionibacterium as compared to the controls. Propionibacterium
is probably derived from the skin and has lipolytic activity.34 We
speculate that the higher relative abundance could be due to the
increased amounts of lipids in the intestines, suggesting that
these bacteria have colonized opportunistically when suitable
energy sources were available.
Other studies have shown that nutrition affects the micro-
biota.12–14 Germ-free mice colonized with human microbiota
showed extensive alterations in the microbiota when changing
diets.12 Murine studies reported that omega-3 polyunsaturated
fatty acids prevented dysbiosis caused by antibiotics35 and
increased the Bifidobacterium population in the intestines.36
Furthermore, the microbiota may influence metabolism, for
example, catabolism of nutrients, extraction of energy, and
production of short chain fatty acids and vitamins.6,10 In
malnourished children, poor nutrition affected normal microbiota
and the subsequent altered microbiota composition caused poor
growth.13 Mice colonized with microbiota from undernourished
children show impaired growth, altered bone morphology, and
metabolic abnormalities in the brain, muscle, and liver, as
compared to mice colonized with healthy children’s microbiota.37
Studies have identified associations between intestinal micro-
biota and growth, but have focused on the development of
obesity.27,38 There is limited knowledge about the relationship
between microbiota and growth in preterm infants. We observed
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that gain in weight z-scores was associated with larger increase in
relative abundance of Bifidobacterium. This indicates that infants
with better growth had a more mature microbiota development.27
Bifidobacterium supplementation has been associated with
improved growth among preterm infants who were treated with
antibiotics.39 A recent study reported an association between early
microbiota in preterm infants and weight gain in infancy.40 The
authors found that Staphylococcus and Enterococcus were
negatively associated with weight gain and that early levels of
Enterobacter, Streptococcus, and Bacteroides were positively
associated with weight gain at 1 month of age.40 Grier et al.28
investigated the relationship between nutrients, intestinal micro-
biota, and growth in term and preterm infants. The authors
divided microbiota development into three successive phases and
reported that the impact of nutrients on growth was affected by
the microbiota phase.28 They also observed that increased
nutrients appeared to promote transition of the microbiota into
the next phase. Furthermore, poor growth was associated with
delays in transitions from one phase to the next one.28
Infants on prolonged PN appeared to have delayed develop-
ment of normal microbiota with reduced microbial diversity and
richness, as well as more Enterococcus during the first weeks of life.
We speculate that this could be due to the smaller human milk
volumes provided for these infants emphasizing the importance
of initiating human milk feeding if tolerated without delay. When
adjusting for BW and sepsis, there were no longer differences
between the PN groups. This could be due a strong association
between low BW, increased risk of infection, and the need for
prolonged PN. Also, low diversity and richness levels may be
associated with increased risk of sepsis.
There are limitations to our study. Due to early termination of
the study, the sample size was smaller than planned for. Thus,
differences between the groups may not have been detected due
to low power. Differences in baseline characteristics, particularly
among the MVP infants, may have influenced the microbiota and
concealed possible effects of the nutrients. The MVP intervention
group had significantly lower mean BW, HC, BW z-scores, and HC
z-score than the controls. Also, the infants in the intervention
group had a higher rate of late-onset sepsis and tended to have
more days on antibiotics as compared to the controls. The
infection as well as the subsequent exposure to antibiotics may
have affected the microbiota.16 Antibiotic use during the 5 days
before sample collection was added as a covariate, but may not
have eliminated the temporary effects on the microbiota.16
Despite attempts to correct for possible confounding factors,
group differences may have had an effect on the intestinal
microbiota that we were unable to adjust for in statistical tests. We
did not collect information about maternal characteristics such as
chorioamnionitis, antenatal antibiotic use, and maternal fever.
These factors might affect the infants’ microbiota and subse-
quently confound the results. Towards the end of our study there
were fewer fecal samples, particularly among the MVP controls.
Thus, the results at the end of the study period should be
evaluated with caution. Because the study included multiple
nutrient interventions, we cannot conclude on associations
between specific nutrients and microbiota composition. However,
the aim of the intervention was to avoid selective nutrient
deficiencies.
CONCLUSION
Microbial responses varied between individuals and few signifi-
cant differences were detected when comparing the groups with
different nutrient supplies. We observed that infants receiving
enhanced nutrient supply maintained microbial richness levels
better than infants receiving standard nutrient supply. MVP infants
on enhanced nutrient supply showed a greater increase
in microbial diversity as compared to MVP controls. Relative
abundance of Bifidobacterium tended to increase more in MVP
infants on standard nutrient supply as compared to MVP infants
on enhanced nutrient supply. However, the lower relative
abundance of Bifidobacterium in the MVP intervention group
may be due to an increase in other microbes, indicated by the
increase in diversity. Relative abundance of Staphylococcus
appeared higher in the fecal samples collected early in EP infants
with enhanced nutrient supply, and was followed by a more
pronounced decrease as compared to EP controls. The nutrient
intervention did not result in increased relative abundance of
pathogenic microbes. Finally, infants who improved their weight
z-scores appeared to have a more mature microbiota develop-
ment, suggesting that there may be a link between improved
growth and healthy microbiota.
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